Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
HOXA5 Inhibits Microglia Pyroptosis in Cerebral Stroke by Regulating FTO-Mediated TMEM59 m6A Demethylation
Abstract:
Microglia pyroptosis promotes neuroinflammation and secondary brain injury in cerebral stroke. Herein, the role of homeoboxA5 (HOXA5) in regulating microglia pyroptosis during the development of cerebral stroke was studied. Cerebral stroke models were established by MCAO and OGD/R treatment. TTC staining and FJB staining were used to assess cerebral infarction size and neuronal damage. The pathogenic alterations in brain tissues were analyzed by HE staining. MTT and flow cytometry assays were used to determine cell viability and pyroptosis, respectively. TMEM59 m6A level was examined using MeRIP assay. The interaction between HOXA5 and FTO was analyzed by dual luciferase reporter gene and ChIP assays. The interaction between YTHDF2 and TMEM59 was investigated using RIP assay. HOXA5 was lowly expressed in cerebral stroke. HOXA5 overexpression reduced MCAO-induced cerebral injury in rats. HOXA5 upregulation inhibited MCAO and OGD/R-induced microglia pyroptosis. HOXA5 transcriptionally activated FTO expression in microglia. FTO overexpression prevented TMEM59 mRNA degradation by reducing YTHDF2-mediated m6A recognition. HOXA5 overexpression inhibited microglia pyroptosis in cerebral stroke by regulating FTO-mediated TMEM59 mRNA m6A modification.
Insights
HomeoboxA5 (HOXA5) deficiency exacerbates cerebral stroke by promoting microglia pyroptosis. HOXA5 upregulation inhibits neuroinflammation and brain injury by regulating FTO-mediated TMEM59 mRNA m6A modification.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Microglia pyroptosis is a key driver of neuroinflammation and secondary brain injury following cerebral stroke.
- Understanding the molecular mechanisms that regulate microglia pyroptosis is crucial for developing effective stroke therapies.
Purpose of the Study:
- To investigate the role of homeoboxA5 (HOXA5) in regulating microglia pyroptosis during cerebral stroke.
- To elucidate the molecular pathway through which HOXA5 influences neuroinflammation and brain injury.
Main Methods:
- Cerebral stroke models were induced using middle cerebral artery occlusion (MCAO) and oxygen-glucose deprivation/reoxygenation (OGD/R) in rats.
- Cell viability, pyroptosis, infarct size, and neuronal damage were assessed using MTT assays, flow cytometry, TTC staining, and FJB staining, respectively.
- Molecular interactions were analyzed via MeRIP, dual luciferase reporter, ChIP, and RIP assays to examine HOXA5, FTO, YTHDF2, and TMEM59 interactions and m6A modification.
Main Results:
- HOXA5 expression was found to be downregulated in cerebral stroke models.
- Overexpression of HOXA5 significantly reduced cerebral injury, infarct size, and neuronal damage in MCAO-induced stroke.
- HOXA5 upregulation inhibited MCAO and OGD/R-induced microglia pyroptosis.
- HOXA5 was shown to transcriptionally activate FTO expression, which in turn prevented TMEM59 mRNA degradation by reducing YTHDF2-mediated m6A modification.
Conclusions:
- HOXA5 plays a protective role in cerebral stroke by inhibiting microglia pyroptosis.
- The HOXA5/FTO/YTHDF2/TMEM59 axis represents a novel therapeutic target for mitigating neuroinflammation and secondary brain injury in stroke.
More Related Videos
05:40AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke
Published on: November 29, 2024
08:23Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology